Search results for " type 2"

showing 10 items of 761 documents

ADIPONECTIN, RESISTIN AND IL-6 PLASMA LEVELS IN SUBJECTS WITH DIABETIC FOOT AND POSSIBLE CORRELATION WITH CLINICAL VARIABLES AND CARDIOVASCULAR CO-MO…

2010

Abstract Introduction It is very suggestive that diabetic foot is characterized by a pronounced inflammatory reaction and the pathogenic significance of this inflammation has received little attention. On this basis the aim of our study was to evaluate plasma levels of adiponectin, resistin and IL-6 in subjects with diabetic foot in comparison with subjects without foot complications. Materials and methods We recruited 34 subjects with type 2 diabetes mellitus and foot ulceration hospitalized for every condition related to diabetic disease, but not for new vascular events (group A). As controls we recruited 37 patients with type 2 diabetes mellitus without foot ulceration (group B) hospital…

Malemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemEndocrinology Diabetes and MetabolismComorbidityInternal medicineDiabetes mellitusMedicineHumansResistinAngiologyOriginal InvestigationAgedInflammationAdiponectinbusiness.industryInterleukin-6Type 2 Diabetes MellitusMiddle Agedmedicine.diseaseComorbidityDiabetic footDiabetic FootADIPONECTIN RESISTIN IL-6EndocrinologyDiabetes Mellitus Type 2Cardiovascular Diseaseslcsh:RC666-701Multivariate AnalysisResistinFemaleAdiponectinbusinessCardiology and Cardiovascular MedicineFoot (unit)
researchProduct

[Osteoporosis and diabetes].

2011

Diabetes mellitus and osteoporosis are chronic diseases with an elevated and growing incidence in the elderly. Recent epidemiological studies have demonstrated an elevated risk of hip, humerus and foot fractures in elder diabetic subjects. While type 1 diabetes is generally associated with a mild reduction in bone mineral density (BMD), type 2 diabetes, more prevalent in old subjects, is frequently linked to a normal or high BMD. Studies on experimental models of diabetes have suggested an altered bone structure that may help to explain the elevated risk of fractures observed in these animals and may as well help to explain the paradox of an incremented risk of fractures in type 2 diabetic …

Malemedicine.medical_specialtylcsh:Internal medicineTime FactorsBone densityOsteoporosisPopulationlcsh:MedicineType 2 diabetesDiabetes Mellitus ExperimentalFractures BoneSex FactorsRheumatologyBone DensityRisk FactorsInternal medicineDiabetes mellitusHyperinsulinemiaMedicineAnimalsHumansHypoglycemic AgentsInsulinHypercalciuriaProspective Studieseducationlcsh:RC31-1245AgedAged 80 and overType 1 diabeteseducation.field_of_studybusiness.industrylcsh:RAge FactorsMiddle Agedmedicine.diseaseRatsEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2OsteoporosisAccidental FallsFemalebusinessFollow-Up StudiesReumatismo
researchProduct

Cacao extract enriched in polyphenols prevents endocrine-metabolic disturbances in a rat model of prediabetes triggered by a sucrose rich diet.

2019

Cocoa extracts rich in polyphenols are used as potential agent for treating diabetes. Cocoa polyphenols have been proved to ameliorate important hallmarks of type-2 diabetes (T2D). They can regulate glucose levels by increasing insulin secretion, promoting β-cell proliferation and a reduction of insulin resistance. In addition, epidemiological evidence indicates that consumption of flavonoid decreases the incidence of T2D.T2D is preceded by a prediabetic state in which the endocrine-metabolic changes described in T2D are already present. Since epidemiological evidence indicates that consumption of flavonoid decreases its incidence, we evaluated possible preventive effects of polyphenol-enri…

Malemedicine.medical_specialtymedicine.disease_causePrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDietary SucroseInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHumansPrediabetesTriglycerides030304 developmental biologyPharmacology0303 health sciencesCacaoGlycogenPlant ExtractsCocoa ExtractHypertriglyceridemiafood and beveragesPolyphenolsGlutathionemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Liver030220 oncology & carcinogenesisInsulin ResistanceOxidative stressJournal of ethnopharmacology
researchProduct

No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Tr…

2014

Abstract Context: High-density lipoproteins (HDLs) from type 2 diabetic patients are unable to counteract the inhibitory effect of oxidized low-density lipoproteins (ox-LDLs) on vasorelaxation. We hypothesized that glitazones, which improve glycemic control and dyslipidemia, could correct this abnormality. Objectives and Design: We compared the ability of HDL from controls (n = 12) and from type 2 diabetic patients before and after 6 months of treatment with either rosiglitazone (n = 11) or pioglitazone (n = 8) to counteract the inhibitory effect of ox-LDL on vasodilatation of rabbit aorta rings. Results: Rosiglitazone induced a decrease in hemoglobin A1c (7.7% ± 1.1% vs 9.8% ± 1.0%, P = .0…

Malemedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismClinical BiochemistryContext (language use)BiochemistryRosiglitazonechemistry.chemical_compoundEndocrinologyHigh-density lipoproteinInternal medicineDiabetes mellitusmedicineAnimalsHumansHypoglycemic AgentsThiazolidinedioneAortaAgedDyslipidemiasPioglitazoneCholesterolbusiness.industryCholesterol HDLBiochemistry (medical)Middle Agedmedicine.diseaseLipoproteins LDLVasodilationEndocrinologyDiabetes Mellitus Type 2chemistryFemaleThiazolidinedionesEndothelium VascularRabbitsLipoproteins HDLRosiglitazonebusinessPioglitazoneDyslipidemiamedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acu…

2015

In patients with heart failure and type 2 diabetes, low glycosylated hemoglobin has been related with higher risk of mortality but information regarding morbidity is scarce. We sought to evaluate the association between glycosylated hemoglobin and 30-day readmission in patients with type 2 diabetes and acute heart failure.Glycosylated hemoglobin was measured before discharge in 835 consecutive patients with acute heart failure and type 2 diabetes. Cox regression analysis adapted for competing events was used.Mean (standard deviation) age was 72.9 (9.6) years and median glycosylated hemoglobin was 7.2% (6.5%-8.0%). Patients treated with insulin or insulin/sulfonylurea/meglitinides were 41.1%…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentType 2 diabetesGastroenterologyPatient ReadmissionRisk AssessmentInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsAgedRetrospective StudiesGlycated HemoglobinHeart FailureProportional hazards modelbusiness.industryInsulinHazard ratioGeneral Medicinemedicine.diseasePrognosisSulfonylureaConfidence intervalPatient DischargeSurvival RateEndocrinologyDiabetes Mellitus Type 2SpainHeart failureAcute DiseaseFemalebusinessFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Association of prestroke metformin use, stroke severity, and thrombolysis outcome

2020

ObjectiveTo evaluate whether pretreatment with metformin (MET) is associated with less stroke severity and better outcome after IV thrombolysis (IVT), we analyzed a cohort of 1,919 patients with stroke with type 2 diabetes mellitus in a multicenter exploratory analysis.MethodsData from patients with diabetes and ischemic stroke treated with IVT were collected within the European Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration. We applied propensity score matching (PSM) to obtain balanced baseline characteristics of patients treated with and without MET.ResultsOf 1,919 patients with stroke with type 2 diabetes who underwent IVT, 757 (39%) had received MET before stroke (MET+),…

Malemedicine.medical_specialtymedicine.medical_treatment610 Medicine & health030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsModified Rankin ScaleInternal medicineDiabetes mellitusEpidemiologymedicineHumansHypoglycemic AgentsThrombolytic Therapycardiovascular diseases10064 Neuroscience Center ZurichStrokeAgedRetrospective Studiesbusiness.industryRecovery of Function10060 Epidemiology Biostatistics and Prevention Institute (EBPI)ThrombolysisMiddle Agedmedicine.diseaseMetformin10040 Clinic for Neurology3. Good healthMetforminStroke2728 Neurology (clinical)Diabetes Mellitus Type 2Propensity score matchingCohortFemaleNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugNeurology
researchProduct

Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.

2004

We have investigated the effects of hypertension associated with diabetes mellitus on polyunsaturated fatty acid biosynthesis. For this purpose, two rat models for these pathologies have been established: a type 1 diabetic hypertensive model obtained by streptozotocin injection to spontaneously hypertensive rat (SHR), followed or not by insulin treatment (experiment 1); a type 2 diabetic hypertensive model by feeding SHR with a fructose enriched diet (experiment 2). Liver gene expression of delta-6 desaturase (D6D), microsomal D6D activities and fatty acid composition of total lipids were estimated. In experiment 1, an increase of linoleic acid (18:2 n-6) level was observed in the streptozo…

Malemedicine.medical_specialtymedicine.medical_treatmentType 2 diabetesFructoseBiochemistryGene Expression Regulation EnzymologicStreptozocinchemistry.chemical_compoundSpontaneously hypertensive ratInternal medicineDiabetes mellitusMicrosomesRats Inbred SHRmedicineDietary CarbohydratesAnimalsHumansInsulinInsulinFatty AcidsFructoseGeneral Medicinemedicine.diseaseStreptozotocinDietRatsDisease Models AnimalEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2LiverLipogenesisHypertensionFatty Acids UnsaturatedMetabolic syndromeStearoyl-CoA Desaturasemedicine.drugBiochimie
researchProduct

Stiffness degree of ankle range of motion in diabetic patients with atypical amputation

2020

SUMMARY In diabetics, foot deformities are risk factors that increase the risk of amputation as a result of developing ulcers. However, knowledge of the influence of plantar stiffness is still limited. The main objective was to describe connections between the degree of stiffness of the ankle, atypical amputation, and the Foot Posture Index (FPI). METHODS 62 diabetic patients, 58 with type 2 and 4 with type 1 (average age 63.35 years) were included. Records of foot deformities were included; A range of motion test of the ankle joint was used to determine the degree of stiffness. An exploratory analysis of the association of foot position and the degree of rigidity was performed. RESULTS The…

Malemedicine.medical_treatmentAmputação0302 clinical medicineReference Valuesrisk factorsRange of Motion ArticularAmputationOrthodonticslcsh:R5-920AnthropometryStiffnessGeneral MedicineMiddle AgedArticulação do tornozelo/fisiopatologiaDiabetic footmedicine.anatomical_structureankle joint/physiopathologyFemalemedicine.symptomRange of motionlcsh:Medicine (General)Foot (unit)diabetic footPosture030209 endocrinology & metabolismAmputation SurgicalStatistics Nonparametric03 medical and health sciencesDiabetes mellitusamputationmedicineHumansAgedFatores de riscobusiness.industryFootPé diabético030229 sport sciencesAnthropometrymedicine.diseaseDiabetic footAnkle joint/physiopathologyCross-Sectional StudiesDiabetes Mellitus Type 1AmputationDiabetes Mellitus Type 2Risk factorsAnklebusinessAnkle JointRevista da Associação Médica Brasileira
researchProduct

Development of comorbidity-adapted exercise protocols for patients with knee osteoarthritis

2014

Mariëtte de Rooij,1 Marike van der Leeden,1,2 Ellis Avezaat,3 Arja Häkkinen,4 Rob Klaver,1 Tjieu Maas,5 Wilfred F Peter,1 Leo D Roorda,1 Willem F Lems,1,6 Joost Dekker1,71Amsterdam Rehabilitation Research Center, Reade, Amsterdam, the Netherlands; 2VU University Medical Center Department of Rehabilitation Medicine, Amsterdam, the Netherlands; 3Sint Lucas Andreas Hospital, Department of Physical Therapy, Amsterdam, the Netherlands; 4Department of Health Sciences, University of Jyväskylä and Jyväskylä Central Hospital, Jyväskylä, Finland; 5HAN University, Institute of Health, GGM, Institute for Sports and Exercise Studies…

Malemedicine.medical_treatmentOsteoarthritislaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled triallawActivities of Daily LivingOrthopedics and Sports MedicineniveltulehdusHearing DisordersDepression (differential diagnoses)Original Researchkomorbiditeettiexercise therapyRehabilitationDepressionta3141General MedicineMiddle AgedOsteoarthritis KneeLow back paincomorbidityTreatment Outcomearthritiscoexisting diseaseHypertensionFemaleChronic Painmedicine.symptomliikuntahoitomedicine.medical_specialtyHeart DiseasesVision DisordersBiomedical Engineeringknee osteoarthritisrehabilitationRheumatologymental disordersmedicineHumansObesityAgedProtocol (science)business.industryRC952-954.6medicine.diseaseComorbidityDiabetes Mellitus Type 2GeriatricsHeart failureClinical Interventions in AgingQuality of LifePhysical therapykuntoutusGeriatrics and GerontologybusinessLow Back PainClinical Interventions in Aging
researchProduct

Q289P mutation in the FGFR2 gene: first report in a patient with type 1 Pfeiffer syndrome.

2008

When normal development and growth of the calvarial sutures is disrupted, craniosynostosis (premature calvarial suture fusion) may result. Classical craniosynostosis syndromes are autosomal dominant traits and include Apert, Pfeiffer, Crouzon, Jackson-Weiss, and Saethre-Chotzen syndromes. In these conditions, there is premature fusion of skull bones leading to an abnormal head shape, ocular hypertelorism with proptosis, and midface hypoplasia. It is known that mutations in the fibroblast growth factor receptors 1, 2, and 3 cause craniosynostosis. We report on a child with a clinically diagnosed Pfeiffer syndrome that shows the missense point mutation Q289P in exon 8 of the FGFR2 gene. This …

Malemusculoskeletal diseasescongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyCraniosynostosisSettore MED/38 - Pediatria Generale E SpecialisticaHumansPoint MutationMedicineMissense mutationReceptor Fibroblast Growth Factor Type 2HypertelorismGeneticsFibrous jointbusiness.industryFibroblast growth factor receptor 2Craniofacial DysostosisInfantDysostosisExonsAcrocephalosyndactyliamedicine.diseaseSkullPhenotypemedicine.anatomical_structurePfeiffer - Crouzon - Apert - Craniosynostosis - Finger and toes abnormalities - Fibroblast growth factor receptorPediatrics Perinatology and Child HealthPfeiffer syndromeFemalemedicine.symptombusiness
researchProduct